The round was led by Andreessen Horowitz, AlleyCorp, and Frist Cressey Ventures with participation from Casdin Capital and Bessemer. The capital will be used to accelerate Thyme Care's technology and advance partnerships with oncologists, health plans, employers, and risk-based entities.

Thyme Care is an oncology care management company providing high-touch, technology-enabled care navigation. Founded to create a better cancer journey for all, Thyme Care guides cancer patients and their caregivers through a complex healthcare system by providing personalized resources, support, and quick access to high-value care. The company's unique approach aligns the incentives of patients, payers and providers and coordinates integrated care that drives value and leads to better outcomes.